Literature DB >> 10411282

Immunomodulating activity of seaweed extract on human lymphocytes in vitro.

B E Shan1, Y Yoshida, E Kuroda, U Yamashita.   

Abstract

Effect of eight kinds of seaweed extract (SWE) on human lymphocytes was studied in vitro. The extracts of Hizikiafusiformis and Meristotheca papulosa (green) markedly stimulated human lymphocytes to proliferate, whereas Eucheuma muricatum and Meristotheca papulosa (red) weakly stimulated proliferation. The responder cells are T cells, because T cells purified by sheep red blood cell (SRBC) rosette-formation were significantly stimulated with SWE, but B cells were not. These extracts enhanced the induction of cytotoxic T lymphocyte (CTL) activity, but failed to enhance natural killer (NK) cell activity. These extracts had a stimulatory effect on immunoglobulin (Ig) production by B cells and tumor necrosis factor (TNF) production by monocytes. The activity of Hizikia fusiformis associated with polysaccharides which were extracted with ethanol and purified by ion-exchange and gel filtration chromatography, whose molecular weight was about 100 kDa. These results suggest that SWE has an immunomodulating activity on human lymphocytes and this ability might be useful for clinical application to treat several diseases such as tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411282     DOI: 10.1016/s0192-0561(98)00063-0

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  3 in total

1.  Immunostimulatory Effect of Enzyme-Modified Hizikia fusiformein a Mouse Model In Vitro and Ex Vivo.

Authors:  Sang-Yong Park; Eunson Hwang; Yu-Kyong Shin; Don-Gil Lee; Jung-Eun Yang; Jae-Hee Park; Tae-Hoo Yi
Journal:  Mar Biotechnol (NY)       Date:  2017-01-30       Impact factor: 3.619

2.  Anticancer drugs from marine flora: an overview.

Authors:  N Sithranga Boopathy; K Kathiresan
Journal:  J Oncol       Date:  2011-02-27       Impact factor: 4.375

3.  GFS, a preparation of Tasmanian Undaria pinnatifida is associated with healing and inhibition of reactivation of Herpes.

Authors:  Russell Cooper; Charles Dragar; Kate Elliot; J H Fitton; John Godwin; Ken Thompson
Journal:  BMC Complement Altern Med       Date:  2002-11-20       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.